Opendata, web and dolomites

SweetBrain SIGNED

A new perspective on the metabolic pathway to neuronal dysfunction: Using organs on a chip to elucidate the role of the brain microvasculature

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SweetBrain project word cloud

Explore the words cloud of the SweetBrain project. It provides you a very rough idea of what is the project "SweetBrain" about.

elucidate    treatment    interactions    illuminating    modeling    underpinnings    endothelium    gatekeeper    chip    regarding    fundamental    metabolically    hyperglycemia    thereby    despite    levels    cure    physiology    clear    pointing    metabolism    unconsidered    observations    metabolites    primarily    decades    diminish    organ    direct    correlated    neurodegeneration    types    separately    little    altering    astrocytes    edge    pass    scarcity    model    limitations    glucose    functionally    overcomes    capacity    models    nvu    hypothesis    perspective    central    vasculature    previously    relationship    crosstalk    elusive    unexplored    metabolic    diabetic    mainly    function    ooc    revolutionize    dysfunction    hypothesize    coupling    coupled    drawing    disease    cutting    neurons    neuronal    drives    brain    subsequently    populations    neurodegenerative    human    questions    communications    homeostasis    mechanisms    diseases    nervous    cns    suggest    neurovascular    revealed    functional    cell    ignoring    vein    remaining    grow   

Project "SweetBrain" data sheet

The following table provides information about the project.

Coordinator
TEL AVIV UNIVERSITY 

Organization address
address: RAMAT AVIV
city: TEL AVIV
postcode: 69978
website: http://www.tau.ac.il/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙487˙438 €
 EC max contribution 1˙487˙438 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-07-01   to  2025-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TEL AVIV UNIVERSITY IL (TEL AVIV) coordinator 1˙487˙438.00

Map

 Project objective

Despite decades of research, the underpinnings of central nervous system (CNS) diseases and clear pathways to effective treatment remain elusive, mainly because of a scarcity of adequate models and methods with the capacity to elucidate human brain physiology. Recent studies suggest that high glucose levels are correlated with neuronal dysfunction and neurodegeneration, yet very little is known about the mechanisms of this relationship. Research in this vein has focused primarily on direct metabolic interactions between neurons and astrocytes, ignoring other cell populations in the neurovascular unit (NVU) that might have a meaningful role. My recent research revealed that the brain vasculature—the ‘gatekeeper’ through which all metabolites must pass to reach the neurons—has direct metabolic coupling with the neurons. Drawing from these observations, I adopt a previously unconsidered perspective and propose that the vasculature drives the neurodegenerative effects of hyperglycemia. Specifically, I hypothesize that high glucose levels change the metabolic function of the brain vasculature, thereby altering the direct endothelium-neuronal crosstalk and triggering neuronal dysfunction. To investigate this hypothesis, I will develop cutting-edge Organ-on-a-Chip (OoC) technology that overcomes the limitations of modeling NVU functionality and cell-cell interactions. Specifically, I will: (1) establish a human-relevant NVU-OoC model for metabolic and functional interactions, in which different cell types grow separately while remaining metabolically and functionally coupled; (2) identify the major metabolic and functional interactions in the human NVU at homeostasis and under diabetic conditions; and subsequently (3) target the vasculature communications to diminish neuronal dysfunction. This research has the potential to revolutionize the study of CNS disease, pointing to an unexplored pathway to a cure, and illuminating fundamental questions regarding brain metabolism.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEETBRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEETBRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

THERMONANO (2018)

Nanoassemblies for the subcutaneous self-administration of anticancer drugs

Read More  

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More  

EXTREME (2020)

The Epistemology and Ethics of Fundamentalism

Read More